Gel Electrophoresis

Gel Electrophoresis

Global Gel Electrophoresis Market to Reach US$2.5 Billion by 2030

The global market for Gel Electrophoresis estimated at US$1.8 Billion in the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Pharma & Biotech Companies End-Use segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$463.3 Million While China is Forecast to Grow at 8.2% CAGR

The Gel Electrophoresis market in the U.S. is estimated at US$463.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Gel Electrophoresis Market - Key Trends and Drivers Summarized

Why Is Gel Electrophoresis Critical in Modern Molecular Biology and Research?

Gel electrophoresis is a fundamental technique in molecular biology and biochemistry, playing a vital role in the analysis and separation of nucleic acids (DNA, RNA) and proteins. But why is this technique so crucial in modern scientific research? Gel electrophoresis is essential because it allows scientists to separate molecules based on their size, charge, or shape, making it possible to visualize, quantify, and analyze genetic material and proteins with precision. This technique is widely used in a range of applications, from genetic fingerprinting and forensic analysis to gene cloning, genetic engineering, and protein research.

In DNA analysis, gel electrophoresis is particularly important for verifying the success of polymerase chain reactions (PCR) or restriction enzyme digestion, which are essential steps in genetic studies and molecular cloning. Researchers use it to confirm the presence, size, and integrity of DNA fragments, enabling them to map genes, study genetic mutations, or even identify individuals in forensic cases. In protein studies, gel electrophoresis helps in determining the purity, molecular weight, and structure of proteins, making it indispensable for drug development and diagnostic applications. Given its versatility and precision, gel electrophoresis remains a cornerstone of molecular biology research, enabling breakthroughs in genomics, proteomics, and personalized medicine.

How Are Technological Advancements Enhancing Gel Electrophoresis?

Technological advancements in gel electrophoresis are significantly improving its precision, speed, and ease of use, making it an even more powerful tool for molecular and biochemical research. One of the key innovations is the development of automated electrophoresis systems. These systems integrate all the steps of electrophoresis—from sample loading to imaging—into a streamlined, automated process. Automated systems reduce human error, provide consistent results, and allow researchers to analyze multiple samples simultaneously, improving throughput and efficiency in laboratories.

Another major advancement is the improvement in gel materials. Traditional agarose and polyacrylamide gels are still widely used, but newer gels have been developed with better resolution and faster run times. For example, precast gels come pre-prepared, eliminating the need for researchers to prepare their own gels, which can be time-consuming and error-prone. Precast gels also offer more uniformity in thickness and composition, ensuring more accurate and reproducible results. Additionally, the development of gradient gels, which vary in density, allows for more precise separation of molecules of different sizes in the same sample, improving the clarity of results.

Fluorescent staining techniques represent another breakthrough in gel electrophoresis. Traditional stains like ethidium bromide have been largely replaced by safer and more sensitive fluorescent dyes that can detect much smaller quantities of nucleic acids and proteins. These dyes bind to the molecules of interest and, when exposed to specific wavelengths of light, produce a bright fluorescent signal, making it easier to detect even trace amounts of material. This sensitivity is particularly valuable in applications like next-generation sequencing or proteomics, where precise quantification is essential.

Additionally, advancements in electrophoresis buffers and running conditions, such as temperature-controlled systems, help prevent the degradation of sensitive biomolecules during the separation process, further improving the reliability of gel electrophoresis. These technological innovations are making gel electrophoresis more robust, accurate, and user-friendly, expanding its use in cutting-edge research fields such as genomics, proteomics, and molecular diagnostics.

Why Is Gel Electrophoresis Essential for DNA, RNA, and Protein Analysis in Research and Diagnostics?

Gel electrophoresis is indispensable for the analysis of DNA, RNA, and proteins, particularly in research and diagnostic settings where precision and accuracy are paramount. For DNA and RNA analysis, gel electrophoresis allows scientists to separate nucleic acids by size, which is crucial for visualizing genetic material after techniques like PCR or restriction enzyme digestion. This separation helps researchers confirm the presence of specific DNA or RNA fragments, assess their quality, and determine their size—key factors in gene mapping, cloning, and sequencing. In forensic science, gel electrophoresis is also used for DNA fingerprinting, where the unique patterns of DNA fragments can be used to identify individuals or verify relationships.

In protein research, gel electrophoresis is essential for analyzing protein composition, structure, and function. Techniques like SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) allow proteins to be separated based on their molecular weight, enabling scientists to study individual proteins in complex mixtures. This is critical for drug development, where researchers need to isolate and study specific proteins involved in disease pathways. Gel electrophoresis is also used to assess protein purity and to detect post-translational modifications, both of which are important in biochemical research and the development of therapeutics.

Moreover, gel electrophoresis plays a vital role in diagnosing genetic disorders, cancers, and infections. For example, it is commonly used to identify mutations in genes that are linked to diseases like cystic fibrosis or sickle cell anemia. By separating and analyzing DNA or RNA from patient samples, clinicians can pinpoint specific genetic abnormalities, allowing for accurate diagnosis and personalized treatment plans. Additionally, electrophoresis-based techniques like Western blotting are used in clinical diagnostics to detect proteins associated with diseases, such as antibodies in autoimmune disorders or viral proteins in infections like HIV.

In summary, gel electrophoresis is a fundamental tool in both research and diagnostics, providing the ability to separate and analyze biological molecules with a high degree of precision. Its versatility and effectiveness in handling nucleic acids and proteins make it a critical technique for advancing our understanding of genetics, disease mechanisms, and drug development.

What Factors Are Driving the Growth of the Gel Electrophoresis Market?

The gel electrophoresis market is experiencing strong growth, driven by a combination of increasing demand for molecular diagnostics, advancements in genomic research, and the need for more efficient and precise laboratory techniques. One of the primary drivers is the expanding field of genomics and proteomics, which relies heavily on electrophoresis for DNA, RNA, and protein analysis. As researchers delve deeper into gene expression studies, genetic mapping, and personalized medicine, the demand for reliable and accurate techniques like gel electrophoresis continues to rise.

Second, the growing need for molecular diagnostics is fueling market growth. With the increasing prevalence of genetic disorders, cancers, and infectious diseases, healthcare providers are turning to molecular diagnostic techniques to accurately identify and treat these conditions. Gel electrophoresis is commonly used in diagnostics to detect genetic mutations, identify infectious agents, and monitor the progression of diseases. As precision medicine becomes a standard approach in healthcare, the need for accurate DNA, RNA, and protein analysis is driving the adoption of electrophoresis technologies in clinical settings.

Third, technological advancements in electrophoresis systems are making the technique more accessible, faster, and easier to use. Automated gel electrophoresis systems, pre-cast gels, and advanced imaging techniques are reducing the complexity and time required for traditional electrophoresis processes, attracting more researchers and clinicians to adopt this technology. These innovations are also improving the accuracy and reproducibility of results, which is essential for applications in diagnostics, drug development, and research.

Additionally, the increasing focus on personalized medicine and biomarker discovery is contributing to the growth of the gel electrophoresis market. As researchers seek to identify specific genetic markers or protein signatures linked to diseases, gel electrophoresis remains a key technique for separating and visualizing these biomolecules. In cancer research, for example, electrophoresis is used to study protein expression patterns and identify potential therapeutic targets, driving the demand for advanced electrophoresis systems.

Moreover, government funding and investments in life science research are further propelling market growth. Many countries are investing heavily in genomics research and molecular diagnostics as part of their healthcare and research initiatives, leading to greater adoption of gel electrophoresis technologies in academic, clinical, and pharmaceutical laboratories.

In conclusion, the gel electrophoresis market is growing due to the rising demand for molecular research, advancements in diagnostic technologies, the need for personalized medicine, and the development of faster, more efficient electrophoresis systems. As these trends continue, gel electrophoresis will remain a cornerstone technique in both research and clinical laboratories, playing a critical role in advancing our understanding of molecular biology and improving healthcare outcomes.

Select Competitors (Total 41 Featured) -
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • C.B.S. Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Gel Electrophoresis – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Use of Gel Electrophoresis in Genomics and Proteomics Drives Market Growth
Role of Gel Electrophoresis in Drug Discovery and Development Processes
Market Opportunities in Emerging Biotechnology Markets
Consumer Demand for Faster, More Accurate Diagnostic Techniques
Advances in Microfluidics and Miniaturization of Electrophoresis Equipment
Environmental and Safety Considerations in Electrophoresis Media Disposal
Role of Gel Electrophoresis in Quality Control in Food and Beverage Industry
Future Trends: Towards Chip-based Electrophoresis and Lab-on-a-Chip Technologies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Laboratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 14: USA Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 15: USA Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: USA 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 17: Canada Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 18: Canada Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: Canada 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 20: Japan Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: Japan Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: Japan 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 23: China Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: China Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: China 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 26: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 29: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Europe 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 32: France Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: France Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: France 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 35: Germany Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Germany Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Germany 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 38: Italy Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Italy Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Italy 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 41: UK Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: UK Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: UK 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 44: Spain Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Spain Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Spain 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 47: Russia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Russia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Russia 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Rest of Europe 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Asia-Pacific 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 59: Australia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Australia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Australia 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 62: India Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: India Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: India 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 65: South Korea Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: South Korea Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: South Korea 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Rest of Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 71: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Latin America 16-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 74: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Latin America 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 77: Argentina Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Argentina Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Argentina 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 80: Brazil Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Brazil Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Brazil 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 83: Mexico Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Mexico Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Mexico 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Latin America 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 89: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Middle East 16-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 92: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Middle East 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 95: Iran Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Iran Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Iran 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 98: Israel Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Israel Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Israel 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Saudi Arabia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Saudi Arabia 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 104: UAE Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: UAE Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: UAE 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of Middle East 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 110: Africa Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Africa Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Africa 16-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings